» Articles » PMID: 11001880

Regulation of CCR6 Chemokine Receptor Expression and Responsiveness to Macrophage Inflammatory Protein-3alpha/CCL20 in Human B Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2000 Sep 26
PMID 11001880
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

The regulation of CCR6 (chemokine receptor 6) expression during B-cell ontogeny and antigen-driven B-cell differentiation was analyzed. None of the CD34(+)Lin(-) hematopoietic stem cell progenitors or the CD34(+)CD19(+) (pro-B) or the CD19(+)CD10(+) (pre-B/immature B cells) B-cell progenitors expressed CCR6. CCR6 is acquired when CD10 is lost and B-cell progeny matures, entering into the surface immunoglobulin D(+) (sIgD(+)) mature B-cell pool. CCR6 is expressed by all bone marrow-, umbilical cord blood-, and peripheral blood-derived naive and/or memory B cells but is absent from germinal center (GC) B cells of secondary lymphoid organs. CCR6 is down-regulated after B-cell antigen receptor triggering and remains absent during differentiation into immunoglobulin-secreting plasma cells, whereas it is reacquired at the stage of post-GC memory B cells. Thus, within the B-cell compartment, CCR6 expression is restricted to functionally mature cells capable of responding to antigen challenge. In transmigration chemotactic assays, macrophage inflammatory protein (MIP)-3alpha/CC chemokine ligand 20 (CCL20) induced vigorous migration of B cells with differential chemotactic preference toward sIgD(-) memory B cells. These data suggest that restricted patterns of CCR6 expression and MIP-3alpha/CCL20 responsiveness are integral parts of the process of B-lineage maturation and antigen-driven B-cell differentiation.

Citing Articles

Astrogliosis in multiple sclerosis and neuro-inflammation: what role for the notch pathway?.

Mora P, Chapouly C Front Immunol. 2023; 14:1254586.

PMID: 37936690 PMC: 10627009. DOI: 10.3389/fimmu.2023.1254586.


Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study.

Cao Y, Yang Y, Hu Q, Wei G J Transl Med. 2023; 21(1):616.

PMID: 37697373 PMC: 10496392. DOI: 10.1186/s12967-023-04474-z.


From Diabetic Nephropathy to End-Stage Renal Disease: The Effect of Chemokines on the Immune System.

Qiu Y, Tang J, Zhao Q, Jiang Y, Liu Y, Liu W J Diabetes Res. 2023; 2023:3931043.

PMID: 37287620 PMC: 10243947. DOI: 10.1155/2023/3931043.


Decreased MIP-3α Production from Antigen-Activated PBMCs in Symptomatic HIV-Infected Subjects.

Zhang F, Sun L, Lafferty M, Margolick J, Garzino-Demo A Pathogens. 2022; 11(1).

PMID: 35055955 PMC: 8778881. DOI: 10.3390/pathogens11010007.


Rifaximin Prevents T-Lymphocytes and Macrophages Infiltration in Cerebellum and Restores Motor Incoordination in Rats with Mild Liver Damage.

Balzano T, Leone P, Ivaylova G, Castro M, Reyes L, Ramon C Biomedicines. 2021; 9(8).

PMID: 34440206 PMC: 8393984. DOI: 10.3390/biomedicines9081002.